日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series

利福平治疗患者中优化他克莫司治疗的挑战:病例系列研究

Houwen, Jeroen P A; de Vries Schultink, Aurelia H M; Peters, Bas J M; Ruigrok, Dieuwertje; Schönwetter, Rob H J; Uijtendaal, Esther V; Sikma, Maaike A

The potential for deprescribing in a palliative oncology patient population: a cross-sectional study

姑息性肿瘤患者群体中减药的可能性:一项横断面研究

van Merendonk, Lisanne N; Peters, Bas J M; Möhlmann, Julia E; Hunting, Cornelis B; Kastelijn, Elisabeth A; van den Broek, Marcel P H

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014

2008年至2014年荷兰确诊转移性非小细胞肺癌患者的药物费用和总体生存率趋势

Cramer-van der Welle, Christine M; Peters, Bas J M; Deenen, Maarten J; Schramel, Franz M N H; van de Garde, Ewoudt M W

Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands

荷兰肌层浸润性或转移性膀胱癌患者的化疗治疗模式和临床结果

Reesink, Daan J; van de Garde, Ewoudt M W; Peters, Bas J M; van der Nat, Paul B; Los, Maartje; Horenblas, Simon; van Melick, Harm H E

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer

系统评价转移性非小细胞肺癌全身治疗的疗效-效果差距

Cramer-van der Welle, Christine M; Peters, Bas J M; Schramel, Franz M N H; Klungel, Olaf H; Groen, Harry J M; van de Garde, Ewoudt M W

Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab)

单克隆抗体患者剂量配制自动化方法的验证:Avastin(贝伐珠单抗)、Remicade(英夫利昔单抗)和Herceptin(曲妥珠单抗)的案例研究

Peters, Bas J M; Capelle, Martinus A H; Arvinte, Tudor; van de Garde, Ewoudt M W